Announcements Trials
Browse Landscape

Phase

Phase 2 89Phase 1 44Phase 3 17Phase 1/2 12Phase 4 4Phase NA 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

EGFR Mutation Positive Non-small Cell Lung Cancer 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Exercise 439Blood Specimen Collection 333Standard of Care 321Magnetic Resonance Spectroscopy 259Radiotherapy 255Surveys and Questionnaires 245Radiosurgery 245Educational Status 230Methods 229Early Intervention, Educational 218Practice Guidelines as Topic 146Interviews as Topic 146Biopsy 146Surgical Procedures, Operative 135Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 110Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 95Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Specimen Handling 79Radiotherapy, Intensity-Modulated 79Colonoscopy 79Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Afatinib × Clear all
NCT01074177 2018-03-09

Understanding Mechanisms of Acquired Resistance to BIBW2992

Massachusetts General Hospital

Phase NA Completed
24 enrolled 10 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01776684 2013-01-28

Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA Analysis

Samsung Medical Center

Phase NA Unknown
200 enrolled
Thoracic

EGFR Mutation Positive Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡